Utility of chromogranin A in the follow-up of bronchial neuroendocrine tumors with symptoms of acromegaly

被引:0
|
作者
Bolanowski, M
Kos-Kudla, B
Marciniak, M
Zatonska, V
机构
[1] Wroclaw Med Univ, Dept Endocrinol Diabetol & Isotope Therapy, Wroclaw, Poland
[2] L Warynski Silesian Med Acad, Dept Pathophysiol & Endocrinol Zabrze, Katowice, Poland
[3] Wroclaw Med Univ, Dept Thorac Surg, Wroclaw, Poland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C7
引用
收藏
页码:31 / 31
页数:1
相关论文
共 50 条
  • [1] SERUM CHROMOGRANIN-A IN THE DIAGNOSIS AND FOLLOW-UP OF NEUROENDOCRINE TUMORS OF THE GASTROENTEROPANCREATIC TRACT
    SCHURMANN, G
    RAETH, U
    WIEDENMANN, B
    BUHR, H
    HERFARTH, C
    WORLD JOURNAL OF SURGERY, 1992, 16 (04) : 697 - 702
  • [2] Follow-Up in Neuroendocrine Neoplasms: Can Chromogranin A Be the Cofounder?
    Martins, D.
    Batista, C.
    Velez, A.
    Macario, F.
    Carrilho, F.
    NEUROENDOCRINOLOGY, 2017, 105 : 310 - 310
  • [3] Role of Chromogranin A in the Diagnosis and Follow-up of Neuroendocrine Tumors Real-World Experience
    Nguyen, Mike
    Li, Michelle
    Travers, Avraham
    Segelov, Eva
    PANCREAS, 2022, 51 (08) : 1007 - 1010
  • [4] Chromogranin A in the Follow-Up of Digestive Neuroendocrine Neoplasms: Is It a Useful Biomarker?
    Merola, E.
    Fave, Delle G.
    Blankenstein, O.
    Wiedenmann, B.
    Pavel, M.
    NEUROENDOCRINOLOGY, 2016, 103 : 49 - 49
  • [5] Neuroendocrine bronchial and thymic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up
    Oberg, K.
    Jelic, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 102 - 103
  • [6] Neuroendocrine bronchial and thymic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up
    Oberg, K.
    Jelic, S.
    ANNALS OF ONCOLOGY, 2009, 20 : 147 - 149
  • [7] Neuroendocrine Tumors Imaging of Treatment and Follow-up
    Migut, Agata E.
    Kaur, Harmeet
    Avritscher, Rony
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2020, 58 (06) : 1161 - +
  • [8] Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Oberg, K.
    Hellman, P.
    Ferolla, P.
    Papotti, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 120 - 123
  • [9] Somatostatin receptor scintigraphy and chromogranin A assay in staging and follow-up of patients with well-differentiated neuroendocrine tumors
    Stokkel, Marcel P. M.
    Rietbergen, Daphne D.
    Korse, Catharina M.
    Taal, Babs G.
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (08) : 731 - 737
  • [10] Serum chromogranin A levels for the diagnosis and follow-up of well-differentiated non-functioning neuroendocrine tumors
    Cheng, Yuejuan
    Sun, Zhao
    Bai, Chunmei
    Yan, Xiaoyan
    Qin, Ran
    Meng, Changting
    Ying, Hongyan
    TUMOR BIOLOGY, 2016, 37 (03) : 2863 - 2869